Novel Transcatheter Solutions for the Treatment of Mitral and Tricuspid Disease
Published: 12 September 2024
-
Views:
1893
-
Likes:
7
-
Views:
1893
-
Likes:
7
-
Up Next
-
6m 20sPart 1 Welcome and Introduction Robert Cubeddu, MD, Dee Dee Wang, Viviana Navas, MD
-
27m 1sPart 2 Mitral Regurgitation (MR) Overview Robert Cubeddu, MD, Dee Dee Wang, Viviana Navas, MD
-
12m 11sPart 3 Functional MR and Case Examples Robert Cubeddu, MD, Dee Dee Wang, Viviana Navas, MD
-
14m 19sPart 4 Tricuspid Regurgitation (TR) Overview Robert Cubeddu, MD, Dee Dee Wang, Viviana Navas, MD
Overview
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Explore case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients.
Learning Objectives
- How to recognize MR/TR
- When to refer for MR/TR
- Practical case-based learnings including the latest transcatheter therapies for mitral and tricuspid disease, with open dialogue amongst moderators and discussants
Target Audience
- General Cardiologists
- Heart Failure Specialists
- Primary Care Physicians
- Residents
- Fellows in Training
More from this programme
Part 1
Welcome and Introduction
Dr Robert Cubeddu gives a brief welcome, outlines the program and provides the educational goals for the session.
| 1 session | |
| Welcome and Introduction | Watch now |
Part 2
Mitral Regurgitation (MR) Overview
Dr Robert Cubeddu, Dr Dee Dee Wang and Dr Viviana Navas offer their perspectives on the significance of mitral regurgitation (MR) and explain why it is important.
| 1 session | |
| Mitral Regurgitation (MR) Overview | Watch now |
Part 3
Functional MR and Case Examples
Faculty explore the characteristics and considerations related to patients with functional MR. They also present and analyze two detailed case examples.
| 1 session | |
| Functional MR and Case Examples | Watch now |
Part 4
Tricuspid Regurgitation (TR) Overview
Dr Robert Cubeddu, Dr Dee Dee Wang and Dr Viviana Navas share their insights into the importance of tricuspid regurgitation (TR).
Part 5
Q&A and Conclusion
Dr Robert Cubeddu, Dr Dee Dee Wang and Dr Viviana Navas address audience questions, providing expert responses and engaging in an interactive discussion.
| 1 session | |
| Audience Q&A and Conclusion | Watch now |
Faculty Biographies
Robert Cubeddu
Cardiologist
Dr Robert Cubeddu is President at NCH Rooney Heart Institute, Florida, US and is board-certified in Cardiovascular Medicine and Interventional Cardiology, with advanced sub-specialty training in Structural Heart Disease.
Dr Cubeddu founded a comprehensive, high-volume premier regional centre of referral in Structural Heart including percutaneous transcatheter valves therapies (TAVR, TMVR, Mitraclip, Valvuloplasty, PVL closure), congenital heart disease interventions (ASD, VSD, PDA, TPVR), and stroke reduction therapies (i.e., LAAC/Watchman and PFO closure). He actively participates as a member of SCAI, ACC and the editorial board of several high-impact peer-review journals.
Dee Dee Wang
Clinical Professor of Medicine
Dr Dee Dee Wang is a Clinical Professor of Medicine at Wayne State University School of Medicine, Michigan, US. She is the first Interventional Imaging Physician inducted as a Fellow of the Society of Cardiovascular Angiography and Interventions. In her early career, she has intraprocedurally guided over 1,500 transcatheter interventions.
Dr Wang is an Interventional Imaging Physician specializing in peri and intraprocedural guidance of catheter based structural and valvular heart disease interventions. Her research interests include advancing patient safety and procedural outcomes utilizing 3D and 4D imaging for Structural Heart Interventions.
Viviana Navas
Section Head of Heart Failure and Director of the Cardiology Fellowship Program
Dr Viviana Navas, M.D is the section head of heart failure and director of the Cardiology Fellowship Program, at the Naples Heart Institute, NCH.
Dr Navas served as Regional Director for Heart Failure, she started the Heart Transplant and mechanical Circulatory support program at the Cleveland Clinic Florida in 2014 and was the medical director until 2021.
Dr Navas went to medical school in la Pontificia Universidad Javeriana in Bogota, Colombia, did internal Medicine Residency and Cardiology fellowship in Cleveland Clinic Florida and finished Advanced Heart Failure and Heart Transplant fellowship at the Cleveland Clinic in Ohio.
Dr Navas’ main interests are advancing the field of heart failure and education, she is very involved with the residency and fellowship programs and every year she participates as speaker in multiple national and international meetings.